Sangamo Therapeutics announces closing of public offering of common stock
Sangamo announced closing of its public offering of 10,000,000 shares of common stock at a price to the public of $7.25 per share. In addition, underwriters have exercised in full their option to purchase an additional 1,500,000 shares of common stock. Total gross proceeds will be $83.4 million. June 26, 2017